Please login to read the full article.
Scrip Regulatory Affairs
US and EU regulations for drug-delivery systems: development considerations for innovative products
14 February 2012
Marielle Fournier and Anne Dupraz-Poiseau
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Trials on trial: 'short-term pain' needed for broken clinical enterprise
- ABHI's code updated with guidance on device ads for healthcare professionals
- GHTF consults on draft guidance on clinical performance studies for IVDs
- EU ministers further strengthen proposed pharmacovigilance rules, as UK MHRA posts handy guide
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
